B is the alternative--is the delay to help BP vaccine profits?
An EUA allows use of unapproved medical products (or unapproved uses of approved medical products) to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by threat agents, such as Covid-19, in response to a declared public health emergency for which there are no adequate, approved, and available alternatives.
I agree that if brilacidin turns out to be an effective treatment for COVID-19 then the incompetence and tardiness of Leo Ehrlich in getting the trials done is indeed unforgivable, especially given the cooperation of FDA in granting FTD and advising on the protocol.
However I think it’s unlikely to be the case. If brilacidin had one tenth of the potential its supporters claim it would have been snatched up by private equity or Big Pharma months ago.